论文部分内容阅读
目的探讨微创清除术联合凝血酶抑制剂局部应用及尿激酶治疗高血压性脑出血的疗效。方法将高血压性脑出血患者随机分为治疗组和对照组,治疗组采用微创清除术联合凝血酶抑制剂及尿激酶治疗;对照组采用微创清除术联合尿激酶治疗。治疗前后分别对其神经功能缺损评分、血肿周围水肿带体积、再出血发生情况、并发症及日常生活能力(ADL)恢复情况进行比较。结果微创清除术联合凝血酶抑制剂及尿激酶治疗高血压性脑出血是一种安全有效的方法,可明显改善患者的预后。
Objective To investigate the curative effect of local application of thrombin inhibitor combined with urokinase in the treatment of hypertensive intracerebral hemorrhage. Methods Patients with hypertensive intracerebral hemorrhage were randomly divided into treatment group and control group. The treatment group was treated with minimally invasive surgical removal combined with thrombin inhibitor and urokinase. The control group was treated with minimally invasive surgical removal combined with urokinase. Before and after treatment, the neurological deficit score, the volume of edema zone around the hematoma, the occurrence of rebleeding, complication and daily living ability (ADL) recovery were compared. Results Minimally invasive surgery combined with thrombin inhibitor and urokinase in the treatment of hypertensive intracerebral hemorrhage is a safe and effective way to significantly improve the prognosis of patients.